Regulation	NN
of	IN
transforming-growth-factor-b1-driven	JJ
lung	NN
fibrosis	NN
by	IN
galectin-3	NN
.	.

RATIONALE	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
dysregulated	VBN
response	NN
to	TO
alveolar	JJ
epithelial	JJ
injury	NN
with	IN
differentiation	NN
of	IN
epithelial	JJ
cells	NNS
and	CC
fibroblasts	NNS
into	IN
matrix-secreting	JJ
myofibroblasts	NNS
resulting	VBG
in	IN
lung	NN
scaring	VBG
.	.

The	DT
prognosis	NN
is	VBZ
poor	JJ
and	CC
there	EX
are	VBP
no	DT
effective	JJ
therapies	NNS
or	CC
reliable	JJ
biomarkers	NNS
.	.

Galectin-3	NN
is	VBZ
a	DT
b-galactoside	NN
binding	NN
lectin	NN
that	WDT
is	VBZ
highly	RB
expressed	VBN
in	IN
fibrotic	JJ
tissue	NN
of	IN
diverse	JJ
etiologies	NNS
.	.

OBJECTIVES	NNS
:	:
To	TO
examine	VB
the	DT
role	NN
of	IN
galectin-3	NN
in	IN
pulmonary	JJ
fibrosis	NN
.	.

METHODS	NNS
:	:
We	PRP
used	VBD
genetic	JJ
deletion	NN
and	CC
pharmacologic	JJ
inhibition	NN
in	IN
well-characterized	JJ
murine	JJ
models	NNS
of	IN
lung	NN
fibrosis	NN
.	.

Further	JJ
mechanistic	JJ
studies	NNS
were	VBD
performed	VBN
in	FW
vitro	FW
and	CC
on	IN
samples	NNS
from	IN
patients	NNS
with	IN
IPF	NN
.	.

MEASUREMENTS	NNS
AND	CC
MAIN	NNS
RESULTS	NNS
:	:
Transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
and	CC
bleomycin-induced	JJ
lung	NN
fibrosis	NN
was	VBD
dramatically	RB
reduced	VBN
in	IN
mice	NNS
deficient	JJ
in	IN
galectin-3	NN
,	,
manifest	JJ
by	IN
reduced	VBN
TGF-b1-induced	JJ
EMT	NN
and	CC
myofibroblast	NN
activation	NN
and	CC
collagen	NN
production	NN
.	.

Galectin-3	NN
reduced	VBD
phosphorylation	NN
and	CC
nuclear	JJ
translocation	NN
of	IN
b-catenin	NN
but	CC
had	VBD
no	DT
effect	NN
on	IN
Smad2/3	NN
phosphorylation	NN
.	.

A	DT
novel	JJ
inhibitor	NN
of	IN
galectin-3	NN
,	,
TD139	NN
,	,
blocked	VBD
TGF-b-induced	JJ
b-catenin	NN
activation	NN
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
and	CC
attenuated	VBD
the	DT
late-stage	JJ
progression	NN
of	IN
lung	NN
fibrosis	NN
after	IN
bleomycin	NN
.	.

There	EX
was	VBD
increased	VBN
expression	NN
of	IN
galectin-3	NN
in	IN
the	DT
bronchoalveolar	JJ
lavage	NN
fluid	NN
and	CC
serum	NN
from	IN
patients	NNS
with	IN
stable	JJ
IPF	NN
compared	VBN
with	IN
nonspecific	JJ
interstitial	JJ
pneumonitis	NN
and	CC
controls	NNS
,	,
which	WDT
rose	VBD
sharply	RB
during	IN
an	DT
acute	JJ
exacerbation	NN
suggesting	VBG
that	IN
galectin-3	NN
may	MD
be	VB
a	DT
marker	NN
of	IN
active	JJ
fibrosis	NN
in	IN
IPF	NN
and	CC
that	IN
strategies	NNS
that	WDT
block	VBP
galectin-3	NN
may	MD
be	VB
effective	JJ
in	IN
treating	VBG
acute	JJ
fibrotic	JJ
exacerbations	NNS
of	IN
IPF	NN
.	.

CONCLUSIONS	NNS
:	:
This	DT
study	NN
identifies	VBZ
galectin-3	NN
as	IN
an	DT
important	JJ
regulator	NN
of	IN
lung	NN
fibrosis	NN
and	CC
provides	VBZ
a	DT
proof	NN
of	IN
principle	NN
for	IN
galectin-3	NN
inhibition	NN
as	IN
a	DT
potential	JJ
novel	JJ
therapeutic	JJ
strategy	NN
for	IN
IPF	NN
.	.

